Literature DB >> 11802667

Feline mammary adenocarcinoma: tumor size as a prognostic indicator.

Jodi R Viste1, Sherry L Myers, Baljit Singh, Elemir Simko.   

Abstract

Mammary carcinomas and adenocarcinomas (MACs) are relatively common tumors in cats. The postexcisional survival period of affected cats is inversely proportional to tumor size, but the reported median survival periods for different tumor size categories is quite variable. This variability diminishes the prognostic value of reported data. In our study, cats with MACs greater than 3 cm in diameter had a 12-month median survival period, whereas those with MACs less than 3 cm in diameter had a 21-month survival period. Survival periods for cats with MACs smaller than 3 cm ranged from 3 to 54 months; therefore, tumor size alone is of limited prognostic value in cats with MACs smaller than 3 cm in diameter. In cats with MACs larger than 3 cm in diameter, tumor size appears to have much higher prognostic relevance, because this study, as well as others, have indicated that cats with MACs greater than 3 cm in diameter have a poor prognosis, with median survival periods ranging from 4 to 12 months.

Entities:  

Mesh:

Year:  2002        PMID: 11802667      PMCID: PMC339085     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  16 in total

Review 1.  Changing views of the role of matrix metalloproteinases in metastasis.

Authors:  A F Chambers; L M Matrisian
Journal:  J Natl Cancer Inst       Date:  1997-09-03       Impact factor: 13.506

2.  Prognosis of malignant mammary tumor in 53 cats.

Authors:  T Ito; T Kadosawa; M Mochizuki; S Matsunaga; R Nishimura; N Sasaki
Journal:  J Vet Med Sci       Date:  1996-08       Impact factor: 1.267

Review 3.  Laminin-binding integrins in tumor progression and metastasis.

Authors:  B L Ziober; C S Lin; R H Kramer
Journal:  Semin Cancer Biol       Date:  1996-06       Impact factor: 15.707

Review 4.  The biochemistry of cancer dissemination.

Authors:  J T Price; M T Bonovich; E C Kohn
Journal:  Crit Rev Biochem Mol Biol       Date:  1997       Impact factor: 8.250

Review 5.  E-cadherin and its associated protein catenins, cancer invasion and metastasis.

Authors:  W G Jiang
Journal:  Br J Surg       Date:  1996-04       Impact factor: 6.939

6.  Prognostic factors in feline mammary carcinoma.

Authors:  K Weijer; A A Hart
Journal:  J Natl Cancer Inst       Date:  1983-04       Impact factor: 13.506

7.  Feline mammary tumors.

Authors:  A A Hayes; S Mooney
Journal:  Vet Clin North Am Small Anim Pract       Date:  1985-05       Impact factor: 2.093

8.  Prognostic factors for feline mammary tumors.

Authors:  E G MacEwen; A A Hayes; H J Harvey; A K Patnaik; S Mooney; S Passe
Journal:  J Am Vet Med Assoc       Date:  1984-07-15       Impact factor: 1.936

9.  Nonhematopoietic neoplasms in cats.

Authors:  A K Patnaik; S K Liu; A I Hurvitz; A J McClelland
Journal:  J Natl Cancer Inst       Date:  1975-04       Impact factor: 13.506

10.  Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.

Authors:  A Knoop; P A Andreasen; J A Andersen; S Hansen; A V Laenkholm; A C Simonsen; J Andersen; J Overgaard; C Rose
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

View more
  3 in total

1.  Sequence variants and haplotype analysis of cat ERBB2 gene: a survey on spontaneous cat mammary neoplastic and non-neoplastic lesions.

Authors:  Sara Santos; Estela Bastos; Cláudia S Baptista; Daniela Sá; Christophe Caloustian; Henrique Guedes-Pinto; Fátima Gärtner; Ivo G Gut; Raquel Chaves
Journal:  Int J Mol Sci       Date:  2012-03-02       Impact factor: 6.208

2.  Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.

Authors:  Ana Catarina Figueira; Catarina Gomes; Joana Tavares de Oliveira; Hugo Vilhena; Júlio Carvalheira; Augusto J F de Matos; Patrícia Dias Pereira; Fátima Gärtner
Journal:  BMC Vet Res       Date:  2014-11-26       Impact factor: 2.741

3.  Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma.

Authors:  Suzanne Rosen; Becky K Brisson; Amy C Durham; Clare M Munroe; Conor J McNeill; Darko Stefanovski; Karin U Sørenmo; Susan W Volk
Journal:  PLoS One       Date:  2020-08-10       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.